Wall Street Zen Downgrades DENTSPLY SIRONA (NASDAQ:XRAY) to Hold

Key Points

• DENTSPLY SIRONA's stock rating has been downgraded from "buy" to "hold" by Wall Street Zen, reflecting a cautious outlook from analysts.
• The consensus rating for DENTSPLY SIRONA among analysts is currently "Hold," with an average target price of $18.64.
• DENTSPLY SIRONA reported a quarterly earnings per share of $0.52, surpassing expectations, but its revenue has decreased by 4.9% compared to the same period last year.

Wall Street Zen downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) from a buy rating to a hold rating in a report published on Saturday morning.

Other research analysts have also recently issued reports about the company. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Friday. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target on the stock. in a research note on Tuesday, April 15th. UBS Group decreased their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research note on Friday. Finally, Barrington Research set a $18.00 price target on DENTSPLY SIRONA and gave the stock an "outperform" rating in a research note on Friday. Twelve research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Trading Up 3.7%

XRAY traded up $0.46 during trading hours on Friday, reaching $12.99. The company's stock had a trading volume of 2,062,655 shares, compared to its average volume of 2,986,787. DENTSPLY SIRONA has a fifty-two week low of $12.16 and a fifty-two week high of $27.48. The stock has a market cap of $2.59 billion, a PE ratio of -2.74, a P/E/G ratio of 0.80 and a beta of 0.94. The business's 50-day moving average is $15.64 and its 200-day moving average is $15.82. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The firm had revenue of $936.00 million for the quarter, compared to analysts' expectations of $929.67 million. During the same period in the prior year, the firm posted $0.49 earnings per share. The firm's quarterly revenue was down 4.9% on a year-over-year basis. As a group, equities research analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -13.50%.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds have recently modified their holdings of the stock. American Century Companies Inc. raised its stake in shares of DENTSPLY SIRONA by 1.6% in the second quarter. American Century Companies Inc. now owns 1,254,688 shares of the medical instruments supplier's stock valued at $19,924,000 after acquiring an additional 20,320 shares in the last quarter. Franklin Resources Inc. purchased a new position in DENTSPLY SIRONA in the second quarter valued at $1,328,000. Legal & General Group Plc increased its holdings in DENTSPLY SIRONA by 2.1% in the second quarter. Legal & General Group Plc now owns 437,144 shares of the medical instruments supplier's stock valued at $6,942,000 after buying an additional 8,814 shares during the last quarter. Magnetar Financial LLC increased its holdings in DENTSPLY SIRONA by 73.6% in the second quarter. Magnetar Financial LLC now owns 32,121 shares of the medical instruments supplier's stock valued at $510,000 after buying an additional 13,619 shares during the last quarter. Finally, Frank Rimerman Advisors LLC purchased a new position in DENTSPLY SIRONA in the second quarter valued at $348,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.